GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nanopharmaceutics Inc (OTCPK:TGRP) » Definitions » Purchase Of Business

Nanopharmaceutics (Nanopharmaceutics) Purchase Of Business : $0.00 Mil (TTM As of Sep. 2018)


View and export this data going back to 2016. Start your Free Trial

What is Nanopharmaceutics Purchase Of Business?

Nanopharmaceutics's purchase of business for the three months ended in Sep. 2018 was $0.00 Mil. It means Nanopharmaceutics spent $0.00 Mil on purchasing business. Nanopharmaceutics's purchase of business for the trailing twelve months (TTM) ended in Sep. 2018 was $0.00 Mil.

Compared with last quarter ($0.00 Mil in Jun. 2018 ), Nanopharmaceutics spent the same money on purchasing business in Sep. 2018 ($0.00 Mil).


Nanopharmaceutics Purchase Of Business Historical Data

The historical data trend for Nanopharmaceutics's Purchase Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanopharmaceutics Purchase Of Business Chart

Nanopharmaceutics Annual Data
Trend Dec15 Dec16 Dec17
Purchase Of Business
- - -

Nanopharmaceutics Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
Purchase Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Nanopharmaceutics Purchase Of Business Calculation

The amount used to purchase business.

Purchase Of Business for the trailing twelve months (TTM) ended in Sep. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nanopharmaceutics Purchase Of Business Related Terms

Thank you for viewing the detailed overview of Nanopharmaceutics's Purchase Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanopharmaceutics (Nanopharmaceutics) Business Description

Traded in Other Exchanges
N/A
Address
14120 NW 126 Terrace, Alachua, FL, USA, 32615
Nanopharmaceutics Inc is a clinical-stage specialty pharmaceutical company. It is engaged in developing oral, topical, and injectable products for cancer, central nervous system (CNS) disorders, and infectious diseases. The company's pipeline products include Triapine, Ammonium Tetrathiomolybdate, and Aza-TdC targeting cancer; NanoBUP, PRX-3140, NP-18-2, and NP-18-3 targeting CNS; and Ramoplanin and NanoDOX.